Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Head and Neck Cancer

  Free Subscription


Articles published in J Clin Oncol

Retrieve available abstracts of 32 articles:
HTML format
Text format



Single Articles


    June 2019
  1. HARARI PM
    Open the Gates for Treatment De-Intensification in Head and Neck Cancer.
    J Clin Oncol. 2019 Jun 13:JCO1901296. doi: 10.1200/JCO.19.01296.
    PubMed     Text format    


    May 2019
  2. FERRIS RL, Cramer JD, Branstetter Iv BF
    Positron Emission Tomography/Computed Tomography in Evaluation of the Clinically N0 Neck in Head and Neck Squamous Cell Carcinoma.
    J Clin Oncol. 2019 May 31:JCO1900544. doi: 10.1200/JCO.19.00544.
    PubMed     Text format    


    February 2019
  3. LOWE VJ, Duan F, Subramaniam RM, Sicks JD, et al
    Multicenter Trial of [(18)F]fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Staging of Head and Neck Cancer and Negative Predictive Value and Surgical Impact in the N0 Neck: Results From ACRIN 6685.
    J Clin Oncol. 2019 Feb 15:JCO1801182. doi: 10.1200/JCO.18.01182.
    PubMed     Text format     Abstract available


    November 2018
  4. JIANG J, Li Y, Shen Q, Rong X, et al
    Effect of Pregabalin on Radiotherapy-Related Neuropathic Pain in Patients With Head and Neck Cancer: A Randomized Controlled Trial.
    J Clin Oncol. 2018 Nov 20:JCO1800896. doi: 10.1200/JCO.18.00896.
    PubMed     Text format     Abstract available


    September 2018
  5. FAKHRY C, Lacchetti C, Rooper LM, Jordan RC, et al
    Human Papillomavirus Testing in Head and Neck Carcinomas: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists Guideline.
    J Clin Oncol. 2018 Sep 6:JCO1800684. doi: 10.1200/JCO.18.00684.
    PubMed     Text format     Abstract available


    August 2018
  6. JANJIGIAN YY, Bendell J, Calvo E, Kim JW, et al
    CheckMate-032 Study: Efficacy and Safety of Nivolumab and Nivolumab Plus Ipilimumab in Patients With Metastatic Esophagogastric Cancer.
    J Clin Oncol. 2018 Aug 15:JCO2017766212. doi: 10.1200/JCO.2017.76.6212.
    PubMed     Text format     Abstract available


    July 2018
  7. GEOFFROIS L, Martin L, De Raucourt D, Sun XS, et al
    Induction Chemotherapy Followed by Cetuximab Radiotherapy Is Not Superior to Concurrent Chemoradiotherapy for Head and Neck Carcinomas: Results of the GORTEC 2007-02 Phase III Randomized Trial.
    J Clin Oncol. 2018 Jul 17:JCO2017762591. doi: 10.1200/JCO.2017.76.2591.
    PubMed     Text format     Abstract available


    June 2018
  8. TAO Y, Auperin A, Sire C, Martin L, et al
    Improved Outcome by Adding Concurrent Chemotherapy to Cetuximab and Radiotherapy for Locally Advanced Head and Neck Carcinomas: Results of the GORTEC 2007-01 Phase III Randomized Trial.
    J Clin Oncol. 2018 Jun 7:JCO2017762518. doi: 10.1200/JCO.2017.76.2518.
    PubMed     Text format     Abstract available


    May 2018
  9. FISHER R
    Questionable Relevance of Leukemia Risk After Radioiodine Ablation of Thyroid Cancer.
    J Clin Oncol. 2018 May 3:JCO2018781534. doi: 10.1200/JCO.2018.78.1534.
    PubMed     Text format    


  10. PICCARDO A, Puntoni M, Verburg FA, Luster M, et al
    Power of Absolute Values to Avoid Data Misinterpretations: The Case of Radioiodine-Induced Leukemia and Myelodysplasia.
    J Clin Oncol. 2018 May 3:JCO2018777318. doi: 10.1200/JCO.2018.77.7318.
    PubMed     Text format    


    March 2018
  11. MA BBY, Lim WT, Goh BC, Hui EP, et al
    Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).
    J Clin Oncol. 2018 Mar 27:JCO2017770388. doi: 10.1200/JCO.2017.77.0388.
    PubMed     Text format     Abstract available


  12. BHATIA AK, Burtness BA, Decker RH
    Postoperative Chemoradiation in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck.
    J Clin Oncol. 2018 Mar 16:JCO2018777987. doi: 10.1200/JCO.2018.77.7987.
    PubMed     Text format    


  13. PORCEDDU SV, Bressel M, Poulsen MG, Stoneley A, et al
    Postoperative Concurrent Chemoradiotherapy Versus Postoperative Radiotherapy in High-Risk Cutaneous Squamous Cell Carcinoma of the Head and Neck: The Randomized Phase III TROG 05.01 Trial.
    J Clin Oncol. 2018 Mar 14:JCO2017770941. doi: 10.1200/JCO.2017.77.0941.
    PubMed     Text format     Abstract available


    February 2018
  14. THAI AA, Rischin D
    High-Dose Cisplatin for Head and Neck Cancer Lives On.
    J Clin Oncol. 2018 Feb 2:JCO2017768614. doi: 10.1200/JCO.2017.76.8614.
    PubMed     Text format    


    December 2017
  15. QUON H, Vapiwala N, Forastiere A, Kennedy EB, et al
    Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline.
    J Clin Oncol. 2017;35:4078-4090.
    PubMed     Text format     Abstract available


  16. FAKHRY C, Zhang Q, Nguyen-Tan PF, Rosenthal DI, et al
    Development and Validation of Nomograms Predictive of Overall and Progression-Free Survival in Patients With Oropharyngeal Cancer.
    J Clin Oncol. 2017;35:4057-4065.
    PubMed     Text format     Abstract available


  17. NORONHA V, Joshi A, Patil VM, Agarwal J, et al
    Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
    J Clin Oncol. 2017 Dec 8:JCO2017749457. doi: 10.1200/JCO.2017.74.9457.
    PubMed     Text format     Abstract available


    November 2017
  18. FORASTIERE AA, Ismaila N, Lewin JS, Nathan CA, et al
    Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    J Clin Oncol. 2017 Nov 27:JCO2017757385. doi: 10.1200/JCO.2017.75.7385.
    PubMed     Text format     Abstract available


  19. HO AS, Kim S, Tighiouart M, Gudino C, et al
    Metastatic Lymph Node Burden and Survival in Oral Cavity Cancer.
    J Clin Oncol. 2017;35:3601-3609.
    PubMed     Text format     Abstract available


    October 2017
  20. VAN DEN WYNGAERT T, Helsen N, Carp L, Hakim S, et al
    Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
    J Clin Oncol. 2017;35:3458-3464.
    PubMed     Text format     Abstract available


  21. CABANILLAS ME, de Souza JA, Geyer S, Wirth LJ, et al
    Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial.
    J Clin Oncol. 2017;35:3315-3321.
    PubMed     Text format     Abstract available


    August 2017
  22. HSU C, Lee SH, Ejadi S, Even C, et al
    Safety and Antitumor Activity of Pembrolizumab in Patients With Programmed Death-Ligand 1-Positive Nasopharyngeal Carcinoma: Results of the KEYNOTE-028 Study.
    J Clin Oncol. 2017 Aug 24:JCO2017733675. doi: 10.1200/JCO.2017.73.3675.
    PubMed     Text format     Abstract available


  23. BROSE MS, Worden FP, Newbold KL, Guo M, et al
    Effect of Age on the Efficacy and Safety of Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer in the Phase III SELECT Trial.
    J Clin Oncol. 2017;35:2692-2699.
    PubMed     Text format     Abstract available


  24. EBISCH RMF, Rutten DWE, IntHout J, Melchers WJG, et al
    Long-Lasting Increased Risk of Human Papillomavirus-Related Carcinomas and Premalignancies After Cervical Intraepithelial Neoplasia Grade 3: A Population-Based Cohort Study.
    J Clin Oncol. 2017;35:2542-2550.
    PubMed     Text format     Abstract available


    May 2017
  25. PETTY RD, Dahle-Smith A, Stevenson DAJ, Osborne A, et al
    Gefitinib and EGFR Gene Copy Number Aberrations in Esophageal Cancer.
    J Clin Oncol. 2017 May 24:JCO2016703934. doi: 10.1200/JCO.2016.70.3934.
    PubMed     Text format     Abstract available


  26. TRIFILETTI DM, Smith A, Mitra N, Grover S, et al
    Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
    J Clin Oncol. 2017;35:1550-1560.
    PubMed     Text format     Abstract available


  27. SZTURZ P, Seiwert TY, Vermorken JB
    How Standard Is Second-Line Cetuximab in Recurrent or Metastatic Head and Neck Cancer in 2017?
    J Clin Oncol. 2017 May 4:JCO2016718072. doi: 10.1200/JCO.2016.71.8072.
    PubMed     Text format    


    March 2017
  28. BAUML J, Seiwert TY, Pfister DG, Worden F, et al
    Pembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II Study.
    J Clin Oncol. 2017 Mar 22:JCO2016701524. doi: 10.1200/JCO.2016.70.1524.
    PubMed     Text format     Abstract available


    February 2017
  29. MARUR S, Li S, Cmelak AJ, Gillison ML, et al
    E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.
    J Clin Oncol. 2017;35:490-497.
    PubMed     Text format     Abstract available


  30. BARTLEY AN, Washington MK, Colasacco C, Ventura CB, et al
    HER2 Testing and Clinical Decision Making in Gastroesophageal Adenocarcinoma: Guideline From the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology.
    J Clin Oncol. 2017;35:446-464.
    PubMed     Text format     Abstract available


    January 2017
  31. FERRAROTTO R, Mitani Y, Diao L, Guijarro I, et al
    Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.
    J Clin Oncol. 2017;35:352-360.
    PubMed     Text format     Abstract available


    December 2016
  32. JANSEN F, Krebber AM, Coupe VM, Cuijpers P, et al
    Cost-Utility of Stepped Care Targeting Psychological Distress in Patients With Head and Neck or Lung Cancer.
    J Clin Oncol. 2016 Dec 5:JCO2016688739.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: